MedTrace Logo

Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma

NCT04341740 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2023-12-13

No results posted yet for this study

Summary

The purpose of this research is to collect health-related information as well as bone marrow and blood specimens to determine if a new form of treatment for patients with kidney and bladder cancer may be possible.

Conditions

Interventions

PROCEDURE

Bone Marrow Aspirate

bone marrow aspiration

Sponsors & Collaborators

  • WindMIL Therapeutics

    collaborator INDUSTRY

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Abhishek Tripathi, MD · University of Oklahoma

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-22
Primary Completion
2021-03-09
Completion
2021-04-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04341740 on ClinicalTrials.gov